Effects of grapefruit juice on the pharmacokinetics of the enantiomers of methadone

Clinical Pharmacology and Therapeutics
Messaoud BenmebarekChin B Eap

Abstract

Cytochrome P450 (CYP) 3A4 is the main CYP isozyme involved in methadone metabolism. We investigated the influence of grapefruit juice, which contains inhibitors of intestinal CYP3A, on the steady-state pharmacokinetics of methadone. For 5 days, 8 patients undergoing methadone maintenance treatment received 200 mL water or grapefruit juice 30 minutes before and again together with their daily dose of methadone. Blood sampling for R-, S-, and R,S-methadone plasma determination was performed over a 24-hour period. CYP3A activity was determined by measuring the plasma 1'-hydroxymidazolam/midazolam ratio. A decrease in the midazolam ratio was measured in all patients after grapefruit juice (mean +/- SD before grapefruit juice, 9.3 +/- 5.9; mean +/- SD after grapefruit juice, 3.9 +/- 1.2; P <.05). Grapefruit juice led to a mean 17% increase in the area under the curve extrapolated to 24 hours for both enantiomers of methadone (range, 3% to 29% [P <.005]; range, -4% to 37% [P <.05]; and range, 1% to 32% [P <.01]; for R-, S-, and R,S-methadone, respectively). A similar increase in peak level and decrease in apparent clearance were measured with grapefruit juice, whereas time to peak level, terminal half-life, and apparent volume during...Continue Reading

Citations

Jun 2, 2009·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Aminah Jatoi
Jan 17, 2007·Critical Care : the Official Journal of the Critical Care Forum·Bruno MégarbaneFrédéric J Baud
Nov 6, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Jinjun WuZhongqiu Liu
Jan 25, 2011·Expert Opinion on Drug Metabolism & Toxicology·Michael J HanleyDavid J Greenblatt
Feb 20, 2008·Veterinary Anaesthesia and Analgesia·Butch KuKanich, Stacy L Borum
Jul 6, 2014·Best Practice & Research. Clinical Anaesthesiology·Andrea M Trescot
Jan 31, 2017·Journal of Psychosocial Nursing and Mental Health Services·Laura G Leahy
Jul 1, 2014·Clinical Pharmacology in Drug Development·David J Greenblatt
May 15, 2010·Cardiovascular Toxicology·Bernd J Zünkler, Maria Wos-Maganga
Nov 26, 2009·Drug and Alcohol Review·Md Haris Robson NoorZuraniSuresh Narayanan
Dec 15, 2010·Drugs·Kay SedenDavid Back
Apr 21, 2006·Expert Review of Neurotherapeutics·Gabriela Rocha Lauretti
Nov 15, 2006·Journal of Clinical Pharmacology·S U Mertens-TalcottV Butterweck
Mar 26, 2019·British Journal of Clinical Pharmacology·Caroline Victorri-VigneauMarie Grall-Bronnec
May 6, 2011·CA: a Cancer Journal for Clinicians·Judith A Paice, Betty Ferrell
Nov 1, 2011·Critical Reviews in Clinical Laboratory Sciences·Bhushan M KapurPeter Selby
Jun 18, 2019·Journal of Addiction Medicine·Muhammed ErshadMichael I Greenberg
Oct 23, 2019·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Avik ChatterjeeTravis P Baggett
Aug 10, 2016·Journal of Clinical Pharmacology·Marina Kawaguchi-SuzukiRhonda M Cooper-DeHoff
Aug 1, 2006·Personalized Medicine·Caroline Flora SamerPierre Dayer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
Nobuhisa UedaJun Nakamura
Clinical Pharmacology and Therapeutics
Shefali M KakarPaul B Watkins
Cancer Chemotherapy and Pharmacology
Nielka P van ErpHans Gelderblom
Clinical Pharmacology and Therapeutics
A S GrossG M Shenfield
© 2022 Meta ULC. All rights reserved